GenMark Diagnostics Inc (GNMK):企業の財務・戦略的SWOT分析

◆英語タイトル:GenMark Diagnostics Inc (GNMK) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C14491
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥44,400見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
GenMark Diagnostics Inc (GenMark) is a medical device company that provides clinical testing systems. The company provides products such as XT-8 systems and ePlex systems. It offers pipeline products such as eSensor 2C 19 genotyping test, eSensor HCV genotyping test, eSensor HCVg direct test, and others. GenMark develops products used in treatment of CNS infections, GI infections, genetic conditions, hepatitis, respiratory infections and sepsis, among others. The company provides educational resources to medical professionals in the areas of cystic fibrosis, respiratory viral panel, thrombophilia and warfarin sensitivity, among others. It operates in the US and Switzerland. GenMark is headquartered in Carlsbad, California, the US.

GenMark Diagnostics Inc Key Recent Developments

Feb 21,2019: GenMark Diagnostics reports fourth quarter and full year 2018 results
Feb 21,2019: Genmark Diagnostics announces expansion of executive leadership team
Jan 08,2019: Genmark Diagnostics provides preliminary operational and financial results for 2018
Dec 26,2018: GenMark Diagnostics Receives FDA 510(k) Market Clearance for its ePlex Blood Culture Identification Fungal Pathogen Panel
Oct 29,2018: GenMark Diagnostics reports third quarter 2018 results

This comprehensive SWOT profile of GenMark Diagnostics Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of GenMark Diagnostics Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

GenMark Diagnostics Inc – Key Information
GenMark Diagnostics Inc – Overview
GenMark Diagnostics Inc – Key Employees
GenMark Diagnostics Inc – Key Employee Biographies
GenMark Diagnostics Inc – Key Operational Heads
GenMark Diagnostics Inc – Major Products and Services
GenMark Diagnostics Inc – History
GenMark Diagnostics Inc – Company Statement
GenMark Diagnostics Inc – Locations And Subsidiaries
GenMark Diagnostics Inc – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

GenMark Diagnostics Inc – Business Description
GenMark Diagnostics Inc – Corporate Strategy
GenMark Diagnostics Inc – SWOT Analysis
SWOT Analysis – Overview
GenMark Diagnostics Inc – Strengths
GenMark Diagnostics Inc – Weaknesses
GenMark Diagnostics Inc – Opportunities
GenMark Diagnostics Inc – Threats
GenMark Diagnostics Inc – Key Competitors

Section 3 – Company Financial Performance Charts

GenMark Diagnostics Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

GenMark Diagnostics Inc, Key Information
GenMark Diagnostics Inc, Key Ratios
GenMark Diagnostics Inc, Share Data
GenMark Diagnostics Inc, Major Products and Services
GenMark Diagnostics Inc, History
GenMark Diagnostics Inc, Key Employees
GenMark Diagnostics Inc, Key Employee Biographies
GenMark Diagnostics Inc, Key Operational Heads
GenMark Diagnostics Inc, Other Locations
GenMark Diagnostics Inc, Subsidiaries
GenMark Diagnostics Inc, Key Manufacturing facilities
GenMark Diagnostics Inc, Key Competitors
GenMark Diagnostics Inc, SWOT Analysis
GenMark Diagnostics Inc, Ratios based on current share price
GenMark Diagnostics Inc, Annual Ratios
GenMark Diagnostics Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

GenMark Diagnostics Inc, Performance Chart
GenMark Diagnostics Inc, Ratio Charts

★海外企業調査レポート[GenMark Diagnostics Inc (GNMK):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Seven Group Holdings Ltd:企業の戦略・SWOT・財務分析
    Seven Group Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Seven Group Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Moog Inc.:企業の戦略・SWOT・財務情報
    Moog Inc. - Strategy, SWOT and Corporate Finance Report Summary Moog Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Gentag Inc:医療機器:M&Aディール及び事業提携情報
    Summary Gentag Inc (Gentag) is a medical device company that patent and develops wireless sensor technology products. The company provides wireless products to diagnostics and personal health. It offers wireless sensor network services. Gentag’s products comprise medication and packaging sensor, dia …
  • Menarini Asia-Pacific Holdings Pte Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary A. Menarini Asia-Pacific Holdings Pte Ltd (A. Menarini Asia-Pacific), formerly Invida Group Pte Ltd, a subsidiary of A. Menarini Industrie Farmaceutiche Riunite Srl is a biopharmaceutical company that develops consumer health care products. The company operates through its divisions includin …
  • Phoenix Children’s Hospital-製薬・医療分野:企業M&A・提携分析
    Summary Phoenix Children's Hospital (PCH) is a healthcare center that provides medical services. The center’s services include anestesiology, dermatology, dermatology, child protection, bone marrow transplants, adolescent medicine, critical care, emergency medicine, developmental paediatrics and fet …
  • Sanofi-aventis Canada Inc-製薬・医療分野:企業M&A・提携分析
    Summary Sanofi-Aventis Canada Inc (Sanofi- Aventis), a subsidiary of Sanofi is a healthcare products provider that discovers, develops, and distributes therapeutic solutions. The company offers skin and hair care, cosmeceuticals, pain relief, health and wellness products. Its skin and hair care prod …
  • MinebeaMitsumi Inc:戦略・SWOT・企業財務分析
    MinebeaMitsumi Inc - Strategy, SWOT and Corporate Finance Report Summary MinebeaMitsumi Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Pharmacyclics LLC:企業の戦略的SWOT分析
    Pharmacyclics LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • BEML Ltd:企業の戦略・SWOT・財務情報
    BEML Ltd - Strategy, SWOT and Corporate Finance Report Summary BEML Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Engie Brasil Energia SA (EGIE3):企業の財務・戦略的SWOT分析
    Engie Brasil Energia SA (EGIE3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Exelixis Inc (EXEL):製薬・医療:M&Aディール及び事業提携情報
    Summary Exelixis Inc (Exelixis) is a biopharmaceutical company that focuses on the development and commercialization of small molecule therapies for the treatment of cancer. The company has three product candidates: Cometriq (Cabozantinib), an inhibitor of multiple receptor tyrosine kinases; Cabomet …
  • NovaBay Pharmaceuticals Inc (NBY):医療機器:M&Aディール及び事業提携情報
    Summary NovaBay Pharmaceuticals Inc (NovaBay), formerly NovaCal Pharmaceuticals Inc is a biopharmaceutical company that discovers and develops eyecare products. The company’s products include skin and wound cleanser, daily lid and lash hygiene spray solutions, and cosetic procedures. Its daily lid a …
  • Oilinvest (Netherlands) BV:企業の戦略的SWOT分析
    Oilinvest (Netherlands) BV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Bio2 Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Bio2 Medical Inc (Bio2 Medical) is a medical device company that develops vascular devices. The company’s products include angel catheter, an inferior vena cava filter for pulmonary embolism protection and access to the central venous system in critically ill patients. Its device is designed …
  • Mitek Systems Inc (MITK):企業の財務・戦略的SWOT分析
    Summary Mitek Systems Inc (Mitek) is a technology company that develops and markets payment and fraud prevention software products. The company offers products such as Mobile Verify, Mobile Docs, Mobile Fill, Mobile Deposit and Multi Check Capture. Its Mobile Verify is a Mitek's ID verification solu …
  • Tampa Electric Co-エネルギー分野:企業M&A・提携分析
    Summary Tampa Electric Company (TEC), a subsidiary of Emera Inc., is an energy utility. It conducts the generation, purchase, transmission, distribution and sale of electricity and the distribution, purchase and sale of natural gas in Florida. The service area for electric operations covers West Cen …
  • Alliance Data Systems Corporation:企業の戦略・SWOT・財務分析
    Alliance Data Systems Corporation - Strategy, SWOT and Corporate Finance Report Summary Alliance Data Systems Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Aker Solutions ASA (AKSO)-石油・ガス分野:企業M&A・提携分析
    Summary Aker Solutions ASA (Aker Solutions) is a global provider of engineering, design, production systems and services to the oil and gas industry. The company offers subsea production equipment and offshore field design, ranging from concept studies and front-end engineering to subsea production …
  • Cisco Systems, Inc.:企業の戦略・SWOT・財務分析
    Cisco Systems, Inc. - Strategy, SWOT and Corporate Finance Report Summary Cisco Systems, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Aeolus Pharmaceuticals Inc (AOLS)-製薬・医療分野:企業M&A・提携分析
    Summary Aeolus Pharmaceuticals Inc (Aeolus) is a biopharmaceutical company that is developing a platform of new compounds for use in cancer, infectious diseases, central nervous system (CNS) diseases, fibrosis and biodefense. The company’s lead product, AEOL 10150 is a broad catalytic antioxidant pa …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆